Global OTC Eyedrop Market Growth 2024-2030

Global OTC Eyedrop Market Growth 2024-2030

OTC (over-the-counter) eyedrops are non-prescription eye solutions used to relieve various common eye issues such as dryness, redness, itching, and irritation. These drops are readily available without the need for a doctor’s prescription and often used for temporary relief of symptoms caused by allergies, environmental factors, or prolonged screen use. OTC eyedrops come in different types, including artificial tears for lubrication, decongestants to reduce redness, and antihistamines to treat allergy-related itching. Some formulations are preservative-free, making them suitable for sensitive eyes or frequent.

The global OTC Eyedrop market size is projected to grow from US$ 3749 million in 2024 to US$ 5321 million in 2030; it is expected to grow at a CAGR of 6.0% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “OTC Eyedrop Industry Forecast” looks at past sales and reviews total world OTC Eyedrop sales in 2023, providing a comprehensive analysis by region and market sector of projected OTC Eyedrop sales for 2024 through 2030. With OTC Eyedrop sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world OTC Eyedrop industry.

This Insight Report provides a comprehensive analysis of the global OTC Eyedrop landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on OTC Eyedrop portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global OTC Eyedrop market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for OTC Eyedrop and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global OTC Eyedrop.

One of the key drivers of the OTC eyedrop market is the increasing prevalence of eye conditions such as dry eye syndrome, eye allergies, and irritation caused by prolonged screen time and environmental factors. With more people using digital devices for extended periods, demand for eyedrops to relieve discomfort and provide moisture has surged. Additionally, the aging population is contributing to the growth of this market, as older adults are more likely to experience eye issues, making OTC solutions a convenient, accessible option for symptom relief.

A significant challenge in the OTC eyedrop market is the potential for consumer confusion and misuse. With a wide variety of products available, including drops for dry eyes, redness, and allergies, consumers may struggle to choose the right formulation for their needs. Misuse or overuse of certain products, especially those containing preservatives or vasoconstrictors, can lead to adverse effects, such as increased eye irritation or dependency. This challenge is compounded by the presence of counterfeit or substandard products, which can further erode consumer confidence.

Alcon, AbbVie, Thea pharmaceuticals, Bausch Health, URSAPHARM, OmniVision Pharma, Rohto, Prestige Consumer Healthcare, LION, Kenvue (VISINE), Santen Pharma, CooperVision, Zhenshiming are the key manufactures in the global OTC Eyedrop market. Among them, Alcon is the largest manufacturer, its revenue share of global market exceeds 21.76% in 2023. The market concentration is high, and top five players accounted for about 60.87% of the world's revenue share.

This report presents a comprehensive overview, market shares, and growth opportunities of OTC Eyedrop market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Contact Lenses Eyedrop
Allergy Eyedrop
Dry Eye Drop
Others

Segmentation by Application:
Online Pharmacies
Retail Pharmacies
Hospital Pharmacies
Optical Channel

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Alcon
AbbVie
Thea pharmaceuticals
Bausch Health
URSAPHARM
OmniVision Pharma
Rohto
Prestige Consumer Healthcare
LION
Kenvue (VISINE)
Santen Pharma
CooperVision
Zhengshiming

Key Questions Addressed in this Report

What is the 10-year outlook for the global OTC Eyedrop market?

What factors are driving OTC Eyedrop market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do OTC Eyedrop market opportunities vary by end market size?

How does OTC Eyedrop break out by Type, by Application?



Please note: The report will take approximately 2 business days to prepare and deliver.